Long-term outcome and relapse patterns in Ewing sarcoma patients with extensive lung/pleural metastases after a complete response to systemic therapy

BACKGROUND: Ewing sarcoma (ES) is sensitive to systemic therapy, including chemotherapy and anti-angiogenesis Tyrosine Kinase Inhibitors(aaTKIs). However, the prognosis of patients with metastatic disease remains poor. Recurrence or distant metastasis after a complete response (CR) or near-CR due to...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jie, Zhi, Xin, Xie, Lu, Sun, Xin, Liu, Xingyu, Liu, Kuisheng, Guo, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9074284/
https://www.ncbi.nlm.nih.gov/pubmed/35524212
http://dx.doi.org/10.1186/s12885-022-09618-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9074284/
https://www.ncbi.nlm.nih.gov/pubmed/35524212
http://dx.doi.org/10.1186/s12885-022-09618-w

Ejemplares similares